Clinical Trials Browser

Has results × Breast Neoplasms × Pemetrexed × Clear all

NCT02624700 2020-07-14

2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer

Phase 2 Terminated

13 enrolled 13 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01803282 2020-06-02

Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors

Phase 1 Completed

236 enrolled 21 charts

BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Colorectal Neoplasms

NCT00470548 2018-01-10

Abraxane and Alimta in Advanced Solid Tumors

Phase 1/2 Terminated

49 enrolled 10 charts

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Breast Neoplasms, Male

NCT00149214 2012-03-21

Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens

Phase 2 Completed

257 enrolled 15 charts

Breast Neoplasms

NCT00325234 2011-05-20

Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast Cancer

Phase 2 Completed

135 enrolled 19 charts

Breast Neoplasms

NCT00190671 2009-11-20

A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer Patients

Phase 1/2 Completed

103 enrolled 19 charts

Breast Neoplasms

NCT00106002 2009-06-01

Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer

Phase 2 Completed

37 enrolled 9 charts

Breast Neoplasms, Breast Neoplasms, Male, Carcinoma, Ductal

NCT00063570 2009-05-29

Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy

Phase 2 Completed

73 enrolled 15 charts

Breast Neoplasms